REUTERS
July 29, 2020 at 18:30 JST
The headquarters of Takeda Pharmaceutical Co. in Osaka (Takeda Pharmaceutical Co. via the Asahi Shimbun)
A group led by Takeda Pharmaceutical Co. have completed test supplies of a blood plasma treatment for COVID-19, but pending regulator approval will likely prevent clinical trials from meeting a July start date.
The CoVIg-19 Plasma Alliance is ready to start shipping vials to study sites once the trial is approved by regulators in the United States, said Julie Kim, president of the plasma-derived therapies unit of Takeda.
The group had originally aimed to begin clinical trials in July. The National Institutes of Health in the United States is the trial sponsor, and is looking at study sites around the world, according to Kim, who also serves as co-leader of the alliance.
The alliance, which also includes Biotest AG, CSL Behring and Octapharma Plasma, is working on a hyperimmune globulin therapy derived from convalescent plasma. It offers a standardized dose of antibodies and doesn’t need to be limited to patients with matching blood types.
Clinical supplies of the treatment were produced at Takeda’s facility in the U.S. state of Georgia and at CSL Behring’s facility in Bern, Switzerland.
If the trials prove successful, the alliance expects to start submissions for regulatory authorization before the end of the year, Kim said.
Takeda virus trial using recovered patients’ blood could start in July
May 14, 2020
S. Korea’s Green Cross seeks phase 2 trials of COVID-19 plasma drug
July 29, 2020
Singapore scientists study genes to fast-track virus vaccine
March 24, 2020
Chinese doctors using plasma therapy on coronavirus, WHO says ‘very valid’ approach
February 18, 2020Takeda Pharma says it is developing coronavirus drug
March 4, 2020
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
A peek through the music industry’s curtain at the producers who harnessed social media to help their idols go global.
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series about Japanese-Americans and their memories of World War II
